This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Psychiatry  • Depression  • Cardiovascular System  • Adverse Effects  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

Christopher M. O’Connor, MD; Wei Jiang, MD; Maragatha Kuchibhatla, PhD; Rajendra H. Mehta, MD, MS; Greg L. Clary, MD; Michael S. Cuffe, MD; Eric J. Christopher, MD; Jude D. Alexander, MD; Robert M. Califf, MD; Ranga R. Krishnan, MD

Arch Intern Med. 2008;168(20):2232-2237.

Background  Recent studies suggest that the use of antidepressants may be associated with increased mortality in patients with cardiac disease. Because depression has also been shown to be associated with increased mortality in these patients, it remains unclear if this association is attributable to the use of antidepressants or to depression.

Methods  To evaluate the association of long-term mortality with antidepressant use and depression, we studied 1006 patients aged 18 years or older with clinical heart failure and an ejection fraction of 35% or less (62% with ischemic disease) between March 1997 and June 2003. The patients were followed up for vital status annually thereafter. Depression status, which was assessed by the Beck Depression Inventory (BDI) scale and use of antidepressants, was prospectively collected. The main outcome of interest was long-term mortality.

Results  Of the study patients, 30.0% were depressed (defined by a BDI score 10) and 24.2% were taking antidepressants (79.6% of these patients were taking selective serotonin reuptake inhibitors [SSRIs] only). The vital status was obtained from all participants at an average follow-up of 972 (731) (mean [SD]) days. During this period, 42.7% of the participants died. Overall, the use of antidepressants (unadjusted hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.03-1.69) or SSRIs only (unadjusted HR, 1.32; 95% CI, 0.99-1.74) was associated with increased mortality. However, the association between antidepressant use (HR, 1.24; 95% CI, 0.94-1.64) and increased mortality no longer existed after depression and other confounders were controlled for. Nonetheless, depression remained associated with increased mortality (HR, 1.33; 95% CI, 1.07-1.66). Similarly, depression (HR, 1.34; 95% CI, 1.08-1.68) rather than SSRI use (HR, 1.10; 95% CI, 0.81-1.50) was independently associated with increased mortality after adjustment.

Conclusion  Our findings suggest that depression (defined by a BDI score 10), but not antidepressant use, is associated with increased mortality in patients with heart failure.

Author Affiliations: Departments of Medicine (Drs O’Connor, Jiang, Mehta, Clary, Cuffe, Christopher, and Califf) and Psychiatry and Behavioral Sciences (Drs Jiang, Clary, Christopher, and Krishnan), and Aging Center (Dr Kuchibhatla), Duke University Medical Center, Durham, North Carolina; and Medicine/Psychiatry Services, Shady Grove Adventist Hospital, Rockville, Maryland (Dr Alexander).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

In This Issue of Archives of Internal Medicine
Arch Intern Med. 2008;168(20):2182.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Depression After Coronary Artery Disease Is Associated With Heart Failure
May et al.
J Am Coll Cardiol 2009;53:1440-1447.
ABSTRACT | FULL TEXT  

Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk.
Denollet and Pedersen
J Am Coll Cardiol 2009;53:947-949.
FULL TEXT  

Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence.
Narayan and Stein
J Am Coll Cardiol 2009;53:959-961.
FULL TEXT